InvestorsHub Logo
icon url

Titan V

07/22/15 3:32 PM

#31654 RE: TomP1 #31652

Yes and a Keytruda trial was stopped early for some indication earlier this year. Open label plus a very effective drug bodes well for ONCS shareholders.